|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
J05AH02
|
|
gptkbp:bioavailability
|
80%
|
|
gptkbp:CASNumber
|
gptkb:132539-06-1
|
|
gptkbp:hasInChIKey
|
gptkb:RWRDLPDLKQPQOW-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C16H28N2O4
|
|
gptkbp:hasSMILES
|
CCOC(=O)C1=C(NC(=O)C)C[C@@H](NC)[C@@H](OCC(C)CC)C1
|
|
gptkbp:hasUNII
|
R7T0KZ6CMO
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
132539-06-1
|
|
gptkbp:isAntiviralDrug
|
true
|
|
gptkbp:IUPACName
|
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:Roche
|
|
gptkbp:meltingPoint
|
205-206 °C
|
|
gptkbp:molecularWeight
|
312.4 g/mol
|
|
gptkbp:name
|
gptkb:Oseltamivir
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prodrugOf
|
oseltamivir carboxylate
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL123
65028
DB00198
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:synonym
|
gptkb:GS-4104
gptkb:Tamiflu
|
|
gptkbp:usedFor
|
treatment of influenza A and B
|
|
gptkbp:bfsParent
|
gptkb:D08402
gptkb:Zyprexa
gptkb:CHEMBL1540
|
|
gptkbp:bfsLayer
|
6
|